Survival update of so14999 a large phase III trial of capecitabine/doxetaxel combination therapy vs docetaxel monotherapy in patients with locally advanced (LABC) or metastatic breast cancer (MBC)
暂无分享,去创建一个
D. Miles | L. Mauriac | J. O’Shaughnessy | W. Lui | S. Vukelja | V. Moiseyenko | G. Cervantes | R. Leonard | G. Hazel | C. Navarro